摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

C6F5CHNCH2CH2NMe2 | 681457-30-7

中文名称
——
中文别名
——
英文名称
C6F5CHNCH2CH2NMe2
英文别名
N,N-dimethyl-2-[(2,3,4,5,6-pentafluorophenyl)methylideneamino]ethanamine
C6F5CHNCH2CH2NMe2化学式
CAS
681457-30-7
化学式
C11H11F5N2
mdl
——
分子量
266.214
InChiKey
IZJSBLFLVCYQLQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    247.0±40.0 °C(Predicted)
  • 密度:
    1.27±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    18
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.36
  • 拓扑面积:
    15.6
  • 氢给体数:
    0
  • 氢受体数:
    7

反应信息

  • 作为反应物:
    描述:
    六羰基钨C6F5CHNCH2CH2NMe2 以 not given 为溶剂, 生成
    参考文献:
    名称:
    钨金属羰基化合物活化CF键的时间分辨红外动力学。
    摘要:
    破坏或激活CH和CF的化学反应具有巨大的合成价值。通过时间分辨红外光谱研究了羰基钨系统的分子内CF键活化。使用CO拉伸段的时间分辨红外光谱法监测溶剂配合物的形成和最终产物。反应速度受钨金属中心和溶剂分子之间分子间配合物形成的限制。与DFT计算的比较表明,在不存在溶剂分子的情况下,具有束缚全氟苯环的分子内配合物在能量上是有利的,但由于配合物的初始几何形状,因此不是主要的动力学产物。
    DOI:
    10.1021/jp055465w
点击查看最新优质反应信息

文献信息

  • Intramolecular oxidative addition of C–F and C–H bonds to [Pt(dba)2]. Crystal structure of [PtCl{Me2NCH2CH2NCH(2,4,5-C6HF3)}]
    作者:Margarita Crespo、Jaume Granell、Mercè Font-Bardı́a、Xavier Solans
    DOI:10.1016/j.jorganchem.2004.06.060
    日期:2004.9
    produced cyclometallated platinum (II) compounds [PtX(Me2NCH2CH2NCHR)] (X = Br, Cl) (2) containing a terdentate [C,N,N′] ligand. The obtained compounds were fully characterized including a structure determination for [PtClMe2NCH2CH2NCH(2,4,5-C6HF3)}] (2d′).
    当化合物[Pt(dba)2 ]与配体RCHNCH 2 CH 2 NMe 2(1a – 1f)(其中R是化芳基环)的反应时,当两个原子存在于邻位时,会激活C–F键。邻位仅含一个取代基的配体的芳基环或C–H键的活化。环的化程度的增加有利于CF和CH键的活化。与卤化进一步反应,生成环属化的(II)化合物[PtX(Me 2 NCH 2 CH 2 NCHR)](X = Br,Cl)(2)含有一个[C,N,N ']的配体。所获得的化合物被充分表征,包括[PtCl Me 2 NCH 2 CH 2 NCH(2,4,5-C 6 HF 3)}]的结构测定(2d ')。
  • Oxidative addition of aryl–halogen bonds to platinum(<scp>II</scp>) and the structure of a complex formed by aryl–fluoride oxidative addition
    作者:Craig M. Anderson、Richard J. Puddephatt、George Ferguson、Alan J. Lough
    DOI:10.1039/c39890001297
    日期:——
    The complexes [PtMe2(Me2NCH2CH2NCHAr)] react by oxidative addition of the aryl–halogen bond when Ar = 2-BrC6H4, 2-CIC6H4, or C6F5 but by ortho-metallation when Ar = 2-FC6H4 or C6H5, and in the case where Ar = C6F5, the oxidative addition product adds acetone across the imine bond and the complex formed has been characterized crystallographically as a hydrogen-bonded dimer; the reactivity to oxidative
    当Ar = 2-BrC 6 H 4,2 -CIC 6 H 4或C 6 F 5时,配合物[PtMe 2(Me 2 NCH 2 CH 2 N CHAr)]通过芳基-卤素键的氧化加成反应,但通过Ar = 2-FC 6 H 4或C 6 H 5时,以及Ar = C 6 F 5时,进行邻位属化,氧化加成产物通过亚胺键加成丙酮,形成的络合物在晶体学上被表征为氢键二聚体。与氧化加成反应的反应性可能与C–X键能相关。
  • Five- and Seven-Membered Metallacycles in [C,N,N′] and [C,N] Cycloplatinated Compounds
    作者:Raquel Martín、Margarita Crespo、Mercè Font-Bardia、Teresa Calvet
    DOI:10.1021/om800864f
    日期:2009.1.26
    The reactions of cis-[Pt(4-C6H4Me)2(μ-SEt2)]2 with ligands ArCH═NCH2CH2NMe2 (Ar = 4-ClC6H4 (1a); 2-BrC6H4 (1b); 2,6-Cl2C6H3 (1c); C6F5 (1d)) and ArCH═NCH2(4-ClC6H4) (Ar = 4-ClC6H4 (1e); 2-BrC6H4 (1f); 2,6-Cl2C6H3 (1g); C6F5 (1h)) were studied. Several types of compounds were formed including (i) [N,N′] coordination compounds (2a, 2c, 2d), (ii) [C,N,N′] platinum(IV) (3b, 3c), [C,N,N′] platinum(II) (4a)
    的反应中的顺式- [PT(4-C 6 H ^ 4 Me)的2(μ-SET 2)] 2与配体ArCH═NCH 2 CH 2 NME 2(AR = 4-CLC 6 ħ 4(1A); 2- BRC 6 ħ 4(1B); 2,6-CL 2 ç 6 ħ 3(1C),C 6 ˚F 5(1D))和ArCH═NCH 2(4-CLC 6 ħ 4)(AR = 4-CLC 6高4(1e); 2-BrC 6 H 4(1f); 2,6-Cl 2 C 6 H 3(1g);研究了C 6 F 5(1h))。形成了几种类型的化合物,包括(i)[N,N']配位化合物(2a,2c,2d),(ii)[C,N,N'](IV)(3b,3c),[C,具有五元属环的N,N'](II)(4a)和[C,N](II)(4e)环属化合物,以及(iii)[C,N,N'](II) )(5c)和具有七元属环的[C,N](II)(5f,
  • Activation of aromatic carbon-fluorine bonds by organoplatinum complexes
    作者:Craig M. Anderson、Margarita Crespo、George Ferguson、Alan J. Lough、Richard J. Puddephatt
    DOI:10.1021/om00039a025
    日期:1992.3
    The ligand Me2NCH2CH2N = CHC6F5 (1a) reacts with [Pt2Me4(mu-SMe2)2] (2) in acetone solution to give sequentially [PtMe2(Me2NCH2CH2N = CHC6F5)] (3a), [PtFMe2(Me2NCH2CH2N = CHC6F5)] (4), and [PtFMe2Me2NCH2CH2NHCH(CH2COMe)C6F4}] (5). Complex 5, which is formed by reaction of 4 with acetone, was characterized by an X-ray structure determination and shown to contain hydrogen-bonded NH...FPt dimers in the solid state. The ligand PhN = CHC6F5 (6) reacts with 2 to give [PtFMe2(PhN = CHC6F4)(SMe2)] which may exist in two isomeric forms 7a and 7b. The reactions to form 4 and 7 give the first examples of oxidative addition of C-F bonds to platinum(II). The ligand Me2NCH2CH2N = CH (2,6-C6H3F2) reacts with 2 to give [PtMe2Me2NCH2CH2N = CH(2,6-C6H3F2)}] (3b), but this failed to give oxidative addition of a C-F bond. The ligands Me2NCH2CH2N = CHAr, Ar = 2,6-, 2,5-, or 2,3-C6H3F2, react with 2 to give [PtMe2(Me2NCH2CH2N = CHAr)], and then CH4 and [PtMe(Me2NCH2CH2N = CHC6H2F2)]. These reactions involve activation of a C-H bond rather than a C-F bond of the aryl group. The results show that activation of a C-F bond of a pentafluorophenyl group is facilitated by incorporation into a monodentate or bidentate nitrogen-donor ligand so that intramolecular oxidative addition can occur, but that C-H bond activation is always easier than C-F bond activation in C6H(x)F5-x groups and that more than two fluorine substituents on the phenyl group are necessary for C-F bond activation to occur.
  • Compound [PtPh<sub>2</sub>(SMe<sub>2</sub>)<sub>2</sub>] as a Versatile Metalating Agent in the Preparation of New Types of [C,N,N‘] Cyclometalated Platinum Compounds
    作者:Margarita Crespo、Mercè Font-Bardia、Xavier Solans
    DOI:10.1021/om030674t
    日期:2004.4.1
    The reactions of [PtPh2(SMe2)(2)] (1) with ligands RCH=NCH2CH2NMe2 (R = C6H5 (2a), 2-BrC6H4 (2b), 2,6-Cl2C6H3 (2c), 2-ClC6H4 (2d), and C6F5 (2e)) produced compounds [PtPh2Me2NCH2CH2NCHR}] (3). Compounds 3 led to formation of three different types of [C,N,N'] platinum compounds, including platinum(II) compounds with a seven-membered metallacycle. The reactions of the cyclometalated compounds with triphenylphosphine were also studied.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫